Clinical conditions that typically elevate prolactin or leptin levels, such as pregnancy, obesity, or treatment with antipsychotic drugs, have also been associated with an increased risk of thromboembolic events [61]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.